Concepedia

Sebastião Cabral Filho

SC

4

Publications

455

Citations

4

H-Index

2005

Active since

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Sebastião Cabral Filho is an author at Vall d'Hebron Hospital Universitari specializing in oncology, medicine, and clinical trials.

Top concepts

Publications per year

2005–2012

4

Publications

4

Phase II Multi-Institutional Randomized Trial of Docetaxel Plus Cisplatin With or Without Fluorouracil in Patients With Untreated, Advanced Gastric, or Gastroesophageal Adenocarcinoma

Jaffer A. Ajani, M Fodor, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2005 · 218 citations · Full text

Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer

José Baselga, J. G. M. Segalla, Henri Roché et al. · Journal of Clinical Oncology · 2012 · 160 citations · Full text

SOLTI-0701: A Multinational Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo When Administered in Combination with Capecitabine in Patients with Locally Advanced or Metastatic Breast Cancer (BC).

José Baselga, H. Roché, F. Costa et al. · Cancer Research · 2009 · 52 citations

, , +17

3LBA SOLTI-0701: A double-blind, randomized phase 2b study evaluating the efficacy and safety of sorafenib (SOR) compared to placebo (PL) when administered in combination with capecitabine (CAP) in patients (pts) with locally advanced (adv) or metastatic (met) breast cancer (BC)

José Baselga, JGM Segalla, Henri Roché et al. · European Journal of Cancer Supplements · 2009 · 25 citations

, , +7

Rows per page

1–4 of 4